GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthEquity Inc (STU:2HE) » Definitions » Days Sales Outstanding

HealthEquity (STU:2HE) Days Sales Outstanding : 32.75 (As of Oct. 2024)


View and export this data going back to 2018. Start your Free Trial

What is HealthEquity Days Sales Outstanding?

HealthEquity's average Accounts Receivable for the three months ended in Oct. 2024 was €99 Mil. HealthEquity's Revenue for the three months ended in Oct. 2024 was €276 Mil. Hence, HealthEquity's Days Sales Outstanding for the three months ended in Oct. 2024 was 32.75.

The historical rank and industry rank for HealthEquity's Days Sales Outstanding or its related term are showing as below:

STU:2HE' s Days Sales Outstanding Range Over the Past 10 Years
Min: 30.03   Med: 33.37   Max: 39.02
Current: 33.15

During the past 12 years, HealthEquity's highest Days Sales Outstanding was 39.02. The lowest was 30.03. And the median was 33.37.

STU:2HE's Days Sales Outstanding is ranked better than
64.59% of 658 companies
in the Healthcare Providers & Services industry
Industry Median: 46.805 vs STU:2HE: 33.15

HealthEquity's Days Sales Outstanding declined from Oct. 2023 (33.79) to Oct. 2024 (32.75).


HealthEquity Days Sales Outstanding Historical Data

The historical data trend for HealthEquity's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HealthEquity Days Sales Outstanding Chart

HealthEquity Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.87 37.45 37.39 38.15 37.02

HealthEquity Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.79 35.49 33.24 32.83 32.75

Competitive Comparison of HealthEquity's Days Sales Outstanding

For the Health Information Services subindustry, HealthEquity's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthEquity's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where HealthEquity's Days Sales Outstanding falls into.



HealthEquity Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

HealthEquity's Days Sales Outstanding for the fiscal year that ended in Jan. 2024 is calculated as

Days Sales Outstanding (A: Jan. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jan. 2023 ) + Accounts Receivable (A: Jan. 2024 )) / count ) / Revenue (A: Jan. 2024 )*Days in Period
=( (89.863 + 96.292) / 2 ) / 917.621*365
=93.0775 / 917.621*365
=37.02

HealthEquity's Days Sales Outstanding for the quarter that ended in Oct. 2024 is calculated as:

Days Sales Outstanding (Q: Oct. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jul. 2024 ) + Accounts Receivable (A: Oct. 2024 )) / count ) / Revenue (A: Oct. 2024 )*Days in Period
=( (99.995 + 97.962) / 2 ) / 275.797*365 / 4
=98.9785 / 275.797*365 / 4
=32.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HealthEquity  (STU:2HE) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


HealthEquity Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of HealthEquity's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


HealthEquity Business Description

Traded in Other Exchanges
Address
15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

HealthEquity Headlines

No Headlines